TINA modified primers allow faster PCR
Questions? Call us at +45 25 32 17 73
In our news section, you will find an overview and content of events Anapa Biotech have attended or will be attending as well as publications, posters, presentations and press releases distributed by Anapa Biotech.
Denmark-based biotech company QuantiBact A/S appoints Søren Morgenthaler Echwald as the company’s new CEO and renames the company to Anapa Biotech. The changes mark an important milestone in the company’s evolution.
Here You will find information on upcoming events in 2014, Anapa Biotech will be attending.
TriLink BioTechnologies Inc. a leader in manufacturing high quality oligonucleotides, nucleoside triphosphates and mRNA, announced that it has signed a licensing agreement with QuantiBact A/S to offer twisted intercalating nucleic acid (TINA) modified oligos.